Human Liver Model Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The human liver model market looks promising with opportunities in education and drug discovery applications. The global human liver model market is expected to grow with a CAGR of 11%-14% from 2020 to 2025. The major drivers for this market are growing focus on developing alternatives for animal testing models and growing initiatives to increase awareness about liver organoids.
Emerging trends, which have a direct impact on the dynamics of the industry, include growing adoption of tissue culture-based clinical diagnostics and technological advancement in liver organoids.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global human liver model market report, please download the report brochure.
In this market, animal model is the largest type of human liver model, whereas drug discovery is the largest application. Growth in various segments of the human liver model market are given below:
The study includes trends and forecast for the global human liver model market by type, application, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that animal models will remain the largest type segment over the forecast period due to the rising demand for preclinical services and the development of biosimilars.
Within this market, drug discovery will remain the largest application segment over the forecast period due to increasing focus on developing alternatives for animal testing models and significant increase in research funding and venture capital investments for the development of liver models.
North America will remain the largest region over the forecast period due to increasing presence of a well-established life science industry, growing awareness of the organoids technology, and increasing government funding for R&D activities in the region.
Features of the Global Human Liver Model Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global human liver model market by type (liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting), applications (education, drug discovery, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global human liver model market?
Q.5 What are the business risks and threats to the global human liver model market?
Q.6 What are the emerging trends in this human liver model market and the reasons behind them?
Q.7 What are some changing demands of customers in this human liver model market?
Q.8 What are the new developments in this human liver model market? Which companies are leading these developments?
Q.9 Who are the major players in this human liver model market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this human liver model market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global human liver model market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Type (Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting), Applications (Education, Drug Discovery, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Russia, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The human liver model market looks promising with opportunities in education and drug discovery applications. The global human liver model market is expected to grow with a CAGR of 11%-14% from 2020 to 2025. The major drivers for this market are growing focus on developing alternatives for animal testing models and growing initiatives to increase awareness about liver organoids.
Emerging trends, which have a direct impact on the dynamics of the industry, include growing adoption of tissue culture-based clinical diagnostics and technological advancement in liver organoids.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global human liver model market report, please download the report brochure.
In this market, animal model is the largest type of human liver model, whereas drug discovery is the largest application. Growth in various segments of the human liver model market are given below:
The study includes trends and forecast for the global human liver model market by type, application, and region as follows:
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
- Liver Organoids
- Liver-on-a-chip
- 2D Models
- Animal Models
- 3D Bioprinting
- Education
- Drug Discovery
- Others
- North America
- United States
- Canada
- Mexico
- Europe
- Russia
- United Kingdom
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that animal models will remain the largest type segment over the forecast period due to the rising demand for preclinical services and the development of biosimilars.
Within this market, drug discovery will remain the largest application segment over the forecast period due to increasing focus on developing alternatives for animal testing models and significant increase in research funding and venture capital investments for the development of liver models.
North America will remain the largest region over the forecast period due to increasing presence of a well-established life science industry, growing awareness of the organoids technology, and increasing government funding for R&D activities in the region.
Features of the Global Human Liver Model Market
- Market Size Estimates: Global human liver model market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global human liver model market size by various segments, such as type and application, in terms of value.
- Regional Analysis: Global human liver model market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different type, application and region for the global human liver model market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global human liver model market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global human liver model market by type (liver organoids, liver-on-a-chip, 2D models, animal models, and 3D bioprinting), applications (education, drug discovery, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global human liver model market?
Q.5 What are the business risks and threats to the global human liver model market?
Q.6 What are the emerging trends in this human liver model market and the reasons behind them?
Q.7 What are some changing demands of customers in this human liver model market?
Q.8 What are the new developments in this human liver model market? Which companies are leading these developments?
Q.9 Who are the major players in this human liver model market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this human liver model market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global human liver model market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Type (Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting), Applications (Education, Drug Discovery, and Others)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Russia, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Human Liver Model Market Trends and Forecast
3.3: Global Human Liver Model Market by Type
3.3.1: Liver Organoids
3.3.2: Liver-on-a-chip
3.3.3: 2D Models
3.3.4: Animal Models
3.3.5: 3D Bioprinting
3.4: Global Human Liver Model Market by Application
3.4.1: Education
3.4.2: Drug Discovery
3.4.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Human Liver Model Market by Region
4.2: North American Human Liver Model Market
4.2.1: Market by Type: Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting
4.2.2: Market by Applications: Education, Drug Discovery, and Others
4.2.3: The United States Human Liver Model Market
4.2.4: The Canadian Human Liver Model Market
4.2.5: The Mexican Human Liver Model Market
4.3: European Human Liver Model Market
4.3.1: Market by Type: Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting
4.3.2: Market by Applications: Education, Drug Discovery, and Others
4.3.3: The Russian Human Liver Model Market
4.3.4: The United Kingdom Human Liver Model Market
4.3.5: The German Human Liver Model Market
4.3.6: The French Human Liver Model Market
4.4: APAC Human Liver Model Market
4.4.1: Market by Type: Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting
4.4.2: Market by Applications: Education, Drug Discovery, and Others
4.4.3: The Chinese Human Liver Model Market
4.4.4: The Indian Human Liver Model Market
4.4.5: The Japanese Human Liver Model Market
4.5: ROW Human Liver Model Market
4.5.1: Market by Type: Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting
4.5.2: Market by Applications: Education, Drug Discovery, and Others
4.5.3: Brazilian Human Liver Model Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Human Liver Model Market by Type
7.1.2: Growth Opportunities for the Global Human Liver Model Market by Application
7.1.3: Growth Opportunities for the Global Human Liver Model Market by Region
7.2: Emerging Trends in the Global Human Liver Model Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Human Liver Model Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Liver Model Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Emulate
8.2: Ascendance Bi
8.3: CN Bi
8.4: Organov
8.5: Cyfuse Biomedical
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Human Liver Model Market Trends and Forecast
3.3: Global Human Liver Model Market by Type
3.3.1: Liver Organoids
3.3.2: Liver-on-a-chip
3.3.3: 2D Models
3.3.4: Animal Models
3.3.5: 3D Bioprinting
3.4: Global Human Liver Model Market by Application
3.4.1: Education
3.4.2: Drug Discovery
3.4.3: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Human Liver Model Market by Region
4.2: North American Human Liver Model Market
4.2.1: Market by Type: Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting
4.2.2: Market by Applications: Education, Drug Discovery, and Others
4.2.3: The United States Human Liver Model Market
4.2.4: The Canadian Human Liver Model Market
4.2.5: The Mexican Human Liver Model Market
4.3: European Human Liver Model Market
4.3.1: Market by Type: Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting
4.3.2: Market by Applications: Education, Drug Discovery, and Others
4.3.3: The Russian Human Liver Model Market
4.3.4: The United Kingdom Human Liver Model Market
4.3.5: The German Human Liver Model Market
4.3.6: The French Human Liver Model Market
4.4: APAC Human Liver Model Market
4.4.1: Market by Type: Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting
4.4.2: Market by Applications: Education, Drug Discovery, and Others
4.4.3: The Chinese Human Liver Model Market
4.4.4: The Indian Human Liver Model Market
4.4.5: The Japanese Human Liver Model Market
4.5: ROW Human Liver Model Market
4.5.1: Market by Type: Liver Organoids, Liver-an-a-Chip, 2D Models, Animal Models, and 3D Bioprinting
4.5.2: Market by Applications: Education, Drug Discovery, and Others
4.5.3: Brazilian Human Liver Model Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Product Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Human Liver Model Market by Type
7.1.2: Growth Opportunities for the Global Human Liver Model Market by Application
7.1.3: Growth Opportunities for the Global Human Liver Model Market by Region
7.2: Emerging Trends in the Global Human Liver Model Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Human Liver Model Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Liver Model Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Emulate
8.2: Ascendance Bi
8.3: CN Bi
8.4: Organov
8.5: Cyfuse Biomedical
8.6: Company
8.7: Company
8.8: Company
8.9: Company
8.10: Company
